. . . . . . . . . . "a(SCHEM:\"LY 294002\") -| path(SDIS:\"Paclitaxel resistance\")" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "The activation of PI-3K/Akt pathway plays an important role in paclitaxel-resistance of ovarian carcinoma cells. PI-3K/Akt inhibitor, LY294002 has a reversal effect on the paclitaxel-resistance of A2780/Taxol cells." . . "Selventa" . . . . "2014-07-03T14:33:20.032+02:00"^^ . . .